| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/08/2004 | CN1178670C Process for prodn. of biological prepn. for antisenesence |
| 12/07/2004 | US6829356 Server-assisted regeneration of a strong secret from a weak secret |
| 12/07/2004 | US6828433 DNA encoding mutated collagen X |
| 12/07/2004 | US6828431 Compositions and methods for the therapy and diagnosis of breast cancer |
| 12/07/2004 | US6828426 VEGF-like factor |
| 12/07/2004 | US6828425 Antibodies that bind human Zven1 |
| 12/07/2004 | US6828424 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent |
| 12/07/2004 | US6828423 Methods and compositions relating to CD39-like polypeptides and nucleic acids |
| 12/07/2004 | US6828420 Small conductance, calcium-activated potassium channels (SKI) |
| 12/07/2004 | US6828418 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 12/07/2004 | US6828415 Dissolving an oligopeptide, such as Bombesin-Antagonist, Protirelin, Somatostatin and Cetrorelix, in acetic acid; transferring the solution to water, and lyophilizing; treating female infertility; gonad protection |
| 12/07/2004 | US6828350 Inhibiting the activity of a picornavirus 3C protease or a cysteine protease with a composition having an orthohydroxy keto aryl core structure |
| 12/07/2004 | US6828343 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 12/07/2004 | US6828335 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis |
| 12/07/2004 | US6828331 Growth hormone secretagogues |
| 12/07/2004 | US6828305 Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 12/07/2004 | US6828304 Lipid-peptide conjugates containing fatty acids of different sizes, which inhibits the binding of Vasoactive intestinal peptide to its receptor |
| 12/07/2004 | US6828303 Treatment of noninsulin dependent diabetes mellitus in a mammal by administering a sustained-release form of a glucagon-like protein (GLP-1 (7-37) having insulintropic activity; drug delivery |
| 12/07/2004 | US6828302 Therapeutic uses of depsipeptides and congeners thereof |
| 12/07/2004 | US6828301 Pharmaceutical compositions for hepatitis C viral protease inhibitors |
| 12/07/2004 | US6828298 Glycoprotein having inhibitory activity against helicobacter pylori colonization |
| 12/07/2004 | US6828297 For therapy of diabetes |
| 12/07/2004 | US6828151 Antisense modulation of hematopoietic cell protein tyrosine kinase expression |
| 12/07/2004 | US6828150 Antigen presenting system and methods for activation of T-cells |
| 12/07/2004 | US6828149 Diagnosis of disease; screening antibodies |
| 12/07/2004 | US6828138 Recombinant sendai virus vector including a gene encoding a chemokine |
| 12/07/2004 | US6828135 Phosphodiester α-GlcNAcase of the lysosomal targeting pathway |
| 12/07/2004 | US6828125 DNA encoding fused di-alpha globins and use thereof |
| 12/07/2004 | US6828123 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases |
| 12/07/2004 | US6828122 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases |
| 12/07/2004 | US6828105 Methods of their use in inhibition of growth of viruses of the picornavirus, calicivirus, togavirus and flavivirus families, as in treatment of a viral infection. The antisense antiviral compounds are substantially uncharged oligomers having a |
| 12/07/2004 | US6828095 Modulators of morphogen expression and methods of identifying the same |
| 12/07/2004 | US6827939 Amino acid sequences for use in detection and treatment of viral infection |
| 12/07/2004 | US6827938 Compositions and methods for improving kidney function |
| 12/07/2004 | US6827935 Method of and compositions for immunization with the pseudomonas V antigen |
| 12/07/2004 | US6827931 Method for treating endocrine disorders |
| 12/07/2004 | CA2217776C Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 12/07/2004 | CA2208673C Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin |
| 12/07/2004 | CA2107516C Antithrombin iii preparation |
| 12/02/2004 | WO2004104217A2 Protein kinase c zeta as a drug target for arthritis and other inflammatory diseases |
| 12/02/2004 | WO2004104204A1 RECOMBINANT GENE MEDICINE OF ADENOVIRUS VECTOR AND GENE p53 FOR TREATING PROLIFERATIVE DISEASES |
| 12/02/2004 | WO2004104200A1 Method of controlling cell proliferation by using novel function of myeloid leukemia factor mlf1 and utilization of the same |
| 12/02/2004 | WO2004104199A2 Modulation of gene expression using dna-dna hybrids |
| 12/02/2004 | WO2004104197A1 Antisense oligonucleotides directed to ribonucleotide reductase r1 and uses thereof in the treatment of cancer |
| 12/02/2004 | WO2004104193A2 Phospholipase c |
| 12/02/2004 | WO2004104176A2 Method for the identification of inhibitors of ornithine carbamoyltransferase, ketol-acid reductoisomerase, and fungal pathogenicity-conferring gene as antibiotics |
| 12/02/2004 | WO2004104041A1 Materials and methods relating to g-protein coupled receptor oligomers |
| 12/02/2004 | WO2004104040A1 Tnf-like secreted protein |
| 12/02/2004 | WO2004104038A1 Control of the intracellular localization of ip3 receptor |
| 12/02/2004 | WO2004104031A2 Modified antiviral peptides with increased activity and cell membrane affinity |
| 12/02/2004 | WO2004104030A2 Peptides modulating the activity of the engrailed transcription factor |
| 12/02/2004 | WO2004104028A1 Anti-inflammatory agents |
| 12/02/2004 | WO2004104027A1 Composition containing angiotensin converting enzyme inhibitory peptide |
| 12/02/2004 | WO2004104020A2 Repeat sequence protein polymer active agent conjugates, methods and uses |
| 12/02/2004 | WO2004104019A2 Anti-inflammatory/anti-microbial peptides for use in dialysis |
| 12/02/2004 | WO2004104018A2 Compositions for delivering peptide yy and pyy agonists |
| 12/02/2004 | WO2004104005A2 Immunosuppressive effects of pteridine derivatives |
| 12/02/2004 | WO2004103996A1 Hepatitis c inhibitor compounds |
| 12/02/2004 | WO2004103410A1 Methods compositions and articles of manufacture for modulating bone growth |
| 12/02/2004 | WO2004103399A1 Use of ulinastatin for treating severe acute respiratory syndrome and pharmaceutical composition of ulinastatin |
| 12/02/2004 | WO2004103397A1 Compositions comprising factor viii and factor ixa for treating haemophilia |
| 12/02/2004 | WO2004103396A1 Compositions for enhanced mucosal delivery of interferon alpha |
| 12/02/2004 | WO2004103395A2 Method of inhibiting cell growth |
| 12/02/2004 | WO2004103394A2 Method and compositions for nerve regeneration |
| 12/02/2004 | WO2004103393A1 CONTROL OF FUNCTION OF INTRACELLULAR Ca ION |
| 12/02/2004 | WO2004103392A1 Method of treatment of systemic injury secondary to burns |
| 12/02/2004 | WO2004103391A1 Hepatic lipid metabolism accelerating agent, hepatic lipid metabolism accelerating health food and process for producing peptide mixture as active ingredient thereof |
| 12/02/2004 | WO2004103390A2 Stable analogs of peptide and polypeptide therapeutics |
| 12/02/2004 | WO2004103389A2 Means for preventing and treating cellular death and their biological applications |
| 12/02/2004 | WO2004103363A1 Use of poly-amminopyrrolecarboxamides alone or in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis |
| 12/02/2004 | WO2004103348A2 Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers |
| 12/02/2004 | WO2004103315A2 Treatment of ophthalmic infections using antimicrobial peptides |
| 12/02/2004 | WO2004103312A2 Peptides useful as hiv fusion inhibitors |
| 12/02/2004 | WO2004103310A2 Methods and compositions for the treatment of metabolic disorders |
| 12/02/2004 | WO2004103304A2 Treatment of t-cell mediated diseases |
| 12/02/2004 | WO2004103297A2 Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis |
| 12/02/2004 | WO2004103295A2 Interleukin-9 antagonist muteins and their pharmacological methods of use |
| 12/02/2004 | WO2004103294A2 Methods and compositions for the prevention and treatment of sepsis |
| 12/02/2004 | WO2004103293A2 Modulators of the p2y10 receptor useful in altering t lymphocyte function |
| 12/02/2004 | WO2004103292A2 Process for manufacture of nematode-extracted anticoagulant protein (nap) |
| 12/02/2004 | WO2004103285A2 Lactoferrin in the treatment of diabetes mellitus |
| 12/02/2004 | WO2004103275A2 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| 12/02/2004 | WO2004103273A2 Inverse agonist and agonist peptides that stimulate/inhibit hair growth |
| 12/02/2004 | WO2004103271A2 Disease prevention and vaccination prior to thymic reactivations |
| 12/02/2004 | WO2004103270A2 Compounds and methods for treatment of thrombosis |
| 12/02/2004 | WO2004103266A2 Protein kinase c peptides for use in withdrawal |
| 12/02/2004 | WO2004103159A2 Methods for modulating endometrium |
| 12/02/2004 | WO2004103149A2 Genes encoding single chain human leukocyte antigen e (hla-e) proteins to prevent natural killer cell-mediated cytotoxicity |
| 12/02/2004 | WO2004096263A3 Human serum albumin-free stabilized interferon liquid formulations |
| 12/02/2004 | WO2004087189A3 Use of bacteriocin for the amelioration of digestive functionality |
| 12/02/2004 | WO2004082707A3 Stabilisation of growth hormones in solution |
| 12/02/2004 | WO2004082569A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d3 (drd3) |
| 12/02/2004 | WO2004078947A3 Use of thyroid-stimulating hormone to induce lipolysis |
| 12/02/2004 | WO2004069870A3 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 12/02/2004 | WO2004067563A8 Peptide inhibitors of toxins derived from ll-37 |
| 12/02/2004 | WO2004060284A3 Method of using colloidal metal-protein composition for treatment of cancer |
| 12/02/2004 | WO2004060264A3 Metastin derivatives and their use |
| 12/02/2004 | WO2004055046A3 Adam like genes of fungi |
| 12/02/2004 | WO2004050834A3 GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER |
| 12/02/2004 | WO2004050027A3 Materials and methods for treating ocular-related disorders |